Repligen Corporation (RGEN): Price and Financial Metrics

RGEN POWR Grades

• Growth is the dimension where RGEN ranks best; there it ranks ahead of 90.37% of US stocks.
• RGEN's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
• RGEN ranks lowest in Value; there it ranks in the 27th percentile.

RGEN Stock Summary

• With a price/earnings ratio of 178.36, Repligen Corp P/E ratio is greater than that of about 96.2% of stocks in our set with positive earnings.
• The price/operating cash flow metric for Repligen Corp is higher than 98.21% of stocks in our set with a positive cash flow.
• With a price/sales ratio of 35.05, Repligen Corp has a higher such ratio than 93.25% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Repligen Corp, a group of peers worth examining would be TECH, VSAT, HZNP, OMCL, and KTOS.
• RGEN's SEC filings can be seen here. And to visit Repligen Corp's official web site, go to www.repligen.com.

RGEN Valuation Summary

• RGEN's EV/EBIT ratio is 123.6; this is 321.84% higher than that of the median Healthcare stock.
• Over the past 243 months, RGEN's price/sales ratio has gone down 6.
• RGEN's price/earnings ratio has moved up 167.9 over the prior 243 months.

Below are key valuation metrics over time for RGEN.

RGEN Growth Metrics

• Its year over year price growth rate is now at 56.1%.
• Its 5 year cash and equivalents growth rate is now at 1009.67%.
• The 2 year revenue growth rate now stands at 83.76%.

Over the past 33 months, RGEN's revenue has gone up $324,803,000.

The table below shows RGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	508.505	83.273	99.933
2021-03-31	433.007	62.357	79.561
2020-12-31	366.26	62.625	59.926
2020-09-30	327.086	65.428	43.832
2020-06-30	302.471	65.904	30.939
2020-03-31	285.701	66.958	23.173

RGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RGEN has a Quality Grade of C, ranking ahead of 53.73% of graded US stocks.
• RGEN's asset turnover comes in at 0.278 -- ranking 160th of 677 Pharmaceutical Products stocks.
• ORMP, PRGO, and TLGT are the stocks whose asset turnover ratios are most correlated with RGEN.

The table below shows RGEN's key quality metrics over time.